معرفی
Rousseau Gama is a Professor of Laboratory and Metabolic Medicine at the University of Wolverhampton's School of Medicine and Clinical Practice, with a focus on improving patient safety through laboratory healthcare delivery. He also serves as a Consultant Chemical Pathologist with Black Country Pathology Services at The Royal Wolverhampton NHS Trust.
- BSc in Biochemistry (University of Liverpool)
- MB ChB (University of Liverpool)
- MSc in Clinical Biochemistry (University of Surrey)
- MD (Chemical Pathology) (University of Liverpool)
His research interests center on optimizing clinical pathways, diagnostic accuracy, and biochemical monitoring for endocrine and metabolic disorders. Key areas include EDTA contamination mitigation, vitamin B12 deficiency, and adrenal/glucose metabolism diagnostics.
Recent publications emphasize clinical biochemistry, endocrinology, and diagnostic improvement, with subfields like EDTA interference, testosterone dynamics, and bile acid metabolism. His work often addresses analytical challenges in laboratory diagnostics.
Rousseau has received grants for research on fecal biomarkers in pregnancy and inflammatory bowel disease, notably Fecal biomarkers in pregnancy and IBD (2015–2019). He has held leadership roles in editorial boards (Journal of Clinical Pathology, Journal of Laboratory and Precision Medicine) and professional committees (Association of Clinical Pathologists).
As an educator, he teaches and examines undergraduate/postgraduate biomedical science modules and has led medical training programs in chemical pathology. His extensive publications (>150) reflect expertise in laboratory medicine and metabolic disorders.
